AstraZeneca boss Pascal Soriot says he's confident the drugmaker's COVID vaccine will thwart a new variant of the virus.
Read More »
AstraZeneca boss Pascal Soriot says he's confident the drugmaker's COVID vaccine will thwart a new variant of the virus.
Read More »The transaction comes after months of speculation that AstraZeneca chief executive Pascal Soriot was hunting for a large target as he sought to take advantage of a soaring share price.
Read More »Britain's AstraZeneca has agreed to buy US drugmaker Alexion Pharmaceuticals for $A52 billion in its largest-ever deal.
Read More »AstraZeneca will start clinical trials to test a combination of its experimental COVID-19 vaccine with Russia's Sputnik V shot aimed at boosting the
Read More »Weighing on risk out of the gates this morning is a touch of vaccine safety uncertainty as some questions need to be answered after news broke that AstraZeneca Plc is likely to conduct an additional global trial to assess the efficacy of its Covid-19 vaccine,
Read More »The Australian sharemarket is expected to open weaker amid subdued global trading due to the Thanksgiving holiday.
Read More »Brent crude oil price rose 2% to US$45.89 a barrel, extending last week’s gains as a recovery in demand is anticipated due to successful
Read More »Australian shares are set to open higher after Oxford and AstraZeneca announce their COVID vaccine results, while Joe Biden picks former Fed chair to be the next US Treasury Secretary.
Read More »US stocks gained on Monday as investor optimism surrounding the development of successful COVID-19 vaccine candidates remained elevated.
Read More »AstraZeneca says its COVID-19 vaccine could be around 90 per cent effective, and is potentially cheaper to make, easier to distribute and faster to scale-up
Read More »